
title: Lancet Oncol 2015-01
date: Sun Jan 19 2020 13:39:07 GMT+0800 (CST)    
categories: baidu
---

# Lancet Oncol 2015-01
size: 35.66 MB
 w.sbdp.hao7188.com/down.asp?id=128493517&token=10b7a629fe015a66ea4efc8c265f7171&bt=Fashion-Descience-project_2015_The-Lancet-Oncology.pdf
 
|- Whole-breast-irradiation-with-or-without-a-boost-for-patients-treated-with-breast-conserving-surgery-for-early-breast-cancer-20-year-follow-up-of-a-ra.pdf - 603.00 kB
|- Use-of-a-tumour-bed-boost-as-part-of-radiotherapy-for-breast-cancer_2015_The-Lancet-Oncology.pdf - 181.00 kB
|- Understanding-cancer-cell-survival-is-key-to-patient-survival_2015_The-Lancet-Oncology.pdf - 294.00 kB
|- Undermining-the-Hippocratic-Oath-the-Medical-Innovation-Bill_2015_The-Lancet-Oncology.pdf - 148.00 kB
|- UK-committee-recommends-HPV-vaccination-for-MSM_2015_The-Lancet-Oncology.pdf - 86.00 kB
|- UK-Cancer-Drugs-Fund-to-reassess-42-agents_2015_The-Lancet-Oncology.pdf - 74.00 kB
|- Towards-effective-adjuvant-treatment-for-urothelial-cancer_2015_The-Lancet-Oncology.pdf - 140.00 kB
|- Towards-a-global-cancer-fund_2015_The-Lancet-Oncology.pdf - 137.00 kB
|- The-paradox-of-preoperative-chemo-radiotherapy-for-rectal-cancer_2015_The-Lancet-Oncology.pdf - 94.00 kB
|- The-cyclin-dependent-kinase-4-6-inhibitor-palbociclib-in-combination-with-letrozole-versus-letrozole-alone-as-first-line-treatment-of-oestrogen-recept.pdf - 471.00 kB
|- Tamoxifen-for-prevention-of-breast-cancer-extended-long-term-follow-up-of-the-IBIS-I-breast-cancer-prevention-trial_2015_The-Lancet-Oncology.pdf - 387.00 kB
|- Sunitinib-in-thymic-carcinoma-enigmas-still-unresolved_2015_The-Lancet-Oncology.pdf - 194.00 kB
|- Sunitinib-in-patients-with-chemotherapy-refractory-thymoma-and-thymic-carcinoma-an-open-label-phase-2-trial_2015_The-Lancet-Oncology.pdf - 456.00 kB
|- Standard-dose-versus-high-dose-conformal-radiotherapy-with-concurrent-and-consolidation-carboplatin-plus-paclitaxel-with-or-without-cetuximab-for-pati.pdf - 470.00 kB
|- Sorafenib-and-everolimus-for-patients-with-unresectable-high-grade-osteosarcoma-progressing-after-standard-treatment-a-non-randomised-phase-2-clinical.pdf - 454.00 kB
|- Smoking-and-mosaic-Y-chromosome-loss_2015_The-Lancet-Oncology.pdf - 91.00 kB
|- Skeletal-muscle-anabolism-in-patients-with-advanced-cancer_2015_The-Lancet-Oncology.pdf - 103.00 kB
|- Silencing-the-voice-of-scientific-reason_2015_The-Lancet-Oncology.pdf - 39.00 kB
|- Safety-and-activity-of-blinatumomab-for-adult-patients-with-relapsed-or-refractory-B-precursor-acute-lymphoblastic-leukaemia-a-multicentre-single-arm-.pdf - 386.00 kB
|- Regenerative-medicine-for-oesophageal-reconstruction-after-cancer-treatment_2015_The-Lancet-Oncology.pdf - 685.00 kB
|- Recalibrating-emergency-care-in-the-UK_2015_The-Lancet-Oncology.pdf - 106.00 kB
|- Radiotherapy-or-surgery-for-the-axilla-in-node-positive-breast-cancer-_2015_The-Lancet-Oncology.pdf - 100.00 kB
|- Radiotherapy-or-surgery-for-the-axilla-in-node-positive-breast-cancer-_2015_The-Lancet-Oncology-V1.pdf - 36.00 kB
|- Radiotherapy-or-surgery-for-the-axilla-in-node-positive-breast-cancer-Authors-reply_2015_The-Lancet-Oncology.pdf - 93.00 kB
|- Quality-of-surgery-has-the-time-come-for-colon-cancer-_2015_The-Lancet-Oncology.pdf - 201.00 kB
|- Putting-palliative-care-on-the-global-health-agenda_2015_The-Lancet-Oncology.pdf - 146.00 kB
|- PSA-testing-for-prostate-cancer-screening_2015_The-Lancet-Oncology.pdf - 48.00 kB
|- PSA-testing-for-prostate-cancer-screening-Authors-reply_2015_The-Lancet-Oncology.pdf - 40.00 kB
|- Prostate-cancer-a-practical-guide_2015_The-Lancet-Oncology.pdf - 548.00 kB
|- POT1-a-genetic-link-for-familial-glioma_2015_The-Lancet-Oncology.pdf - 91.00 kB
|- PARP-inhibitors-in-BRCA-mutation-associated-ovarian-cancer_2015_The-Lancet-Oncology.pdf - 199.00 kB
|- Panitumumab-plus-radiotherapy-versus-chemoradiotherapy-in-patients-with-unresected-locally-advanced-squamous-cell-carcinoma-of-the-head-and-neck-CONCE.pdf - 442.00 kB
|- Ovarian-suppression-and-breast-cancer_2015_The-Lancet-Oncology.pdf - 199.00 kB
|- Outcomes-and-endpoints-in-trials-of-cancer-treatment-the-past-present-and-future_2015_The-Lancet-Oncology.pdf - 263.00 kB
|- Outcomes-and-endpoints-in-cancer-trials-bridging-the-divide_2015_The-Lancet-Oncology.pdf - 627.00 kB
|- Osteosarcoma-better-treatment-through-better-trial-design_2015_The-Lancet-Oncology.pdf - 205.00 kB
|- Organ-preservation-in-rectal-cancer-have-all-questions-been-answered-_2015_The-Lancet-Oncology.pdf - 3.10 MB
|- Oncology-drug-market-worth-predicted-to-increase_2015_The-Lancet-Oncology.pdf - 84.00 kB
|- Olaparib-combined-with-chemotherapy-for-recurrent-platinum-sensitive-ovarian-cancer-a-randomised-phase-2-trial_2015_The-Lancet-Oncology.pdf - 410.00 kB
|- Nivolumab-success-in-untreated-metastatic-melanoma_2015_The-Lancet-Oncology.pdf - 98.00 kB
|- LUX-Lung-determining-the-best-EGFR-inhibitor-in-NSCLC-_2015_The-Lancet-Oncology.pdf - 157.00 kB
|- Lung-cancer-screening-with-low-dose-CT-more-questions-than-answers_2015_The-Lancet-Oncology.pdf - 48.00 kB
|- Lung-cancer-screening-with-low-dose-CT-more-questions-than-answers-Author-s-reply_2015_The-Lancet-Oncology.pdf - 39.00 kB
|- Looking-for-predictive-markers-in-breast-cancer_2015_The-Lancet-Oncology.pdf - 38.00 kB
|- Looking-for-predictive-markers-in-breast-cancer-Authors-reply_2015_The-Lancet-Oncology.pdf - 45.00 kB
|- Inhibition-of-mutant-IDH1-in-acute-myeloid-leukaemia_2015_The-Lancet-Oncology.pdf - 98.00 kB
|- Immunotherapy-improves-overall-survival-in-pancreatic-cancer_2015_The-Lancet-Oncology.pdf - 102.00 kB
|- Immediate-versus-deferred-chemotherapy-after-radical-cystectomy-in-patients-with-pT3-pT4-or-N-M0-urothelial-carcinoma-of-the-bladder-EORTC-30994-an-in.pdf - 555.00 kB
|- Ibrutinib-for-previously-untreated-and-relapsed-or-refractory-chronic-lymphocytic-leukaemia-with-TP53-aberrations-a-phase-2-single-arm-trial_2015_The-.pdf - 419.00 kB
|- IBIS-I-tamoxifen-update-maturity-brings-questions_2015_The-Lancet-Oncology.pdf - 162.00 kB
|- HPV-vaccination-not-linked-to-multiple-sclerosis_2015_The-Lancet-Oncology.pdf - 69.00 kB
|- How-to-bat-a-curve-ball_2015_The-Lancet-Oncology.pdf - 142.00 kB
|- Global-burden-of-cancer-attributable-to-high-body-mass-index-in-2012-a-population-based-study_2015_The-Lancet-Oncology.pdf - 500.00 kB
|- Galeterone-activity-in-castration-resistant-prostate-cancer_2015_The-Lancet-Oncology.pdf - 84.00 kB
|- FDA-approves-new-upgraded-Gardasil-9_2015_The-Lancet-Oncology.pdf - 199.00 kB
|- Fashion-Descience-project_2015_The-Lancet-Oncology.pdf - 313.00 kB
|- Familial-gastric-cancer-genetic-susceptibility-pathology-and-implications-for-management_2015_The-Lancet-Oncology.pdf - 5.80 MB
|- Expanded-access-programmes-patient-interests-versus-clinical-trial-integrity_2015_The-Lancet-Oncology.pdf - 125.00 kB
|- European-Commission-drops-scientific-advisor_2015_The-Lancet-Oncology.pdf - 86.00 kB
|- EGFR-based-bioradiotherapy-in-SCCHN_2015_The-Lancet-Oncology.pdf - 94.00 kB
|- Dual-HER2-inhibition-and-paclitaxel-in-metastatic-breast-cancer_2015_The-Lancet-Oncology.pdf - 69.00 kB
|- Dose-escalation-in-lung-cancer-have-we-gone-full-circle-_2015_The-Lancet-Oncology.pdf - 151.00 kB
|- Disease-free-survival-after-complete-mesocolic-excision-compared-with-conventional-colon-cancer-surgery-a-retrospective-population-based-study_2015_Th.pdf - 377.00 kB
|- Courage-Unmasked_2015_The-Lancet-Oncology.pdf - 864.00 kB
|- Correction-to-Lancet-Oncol-2015-16-91_2015_The-Lancet-Oncology.pdf - 138.00 kB
|- Correction-to-Lancet-Oncol-2015-16-87_2015_The-Lancet-Oncology.pdf - 31.00 kB
|- Correction-to-Lancet-Oncol-2015-16-52_2015_The-Lancet-Oncology.pdf - 138.00 kB
|- Correction-to-Lancet-Oncol-2014-15-1195-206_2015_The-Lancet-Oncology.pdf - 138.00 kB
|- Correction-to-Lancet-Oncol-2012-13-817-818-822_2015_The-Lancet-Oncology.pdf - 138.00 kB
|- Commercial-solariums-banned-in-Australia_2015_The-Lancet-Oncology.pdf - 102.00 kB
|- Combined-treatment-for-only-half-of-Hodgkin-s-patients_2015_The-Lancet-Oncology.pdf - 68.00 kB
|- Chemoradiotherapy-with-or-without-panitumumab-in-patients-with-unresected-locally-advanced-squamous-cell-carcinoma-of-the-head-and-neck-CONCERT-1-a-ra.pdf - 422.00 kB
|- CDK4-6-inhibitors-in-luminal-breast-cancer_2015_The-Lancet-Oncology.pdf - 189.00 kB
|- Carbon-ion-radiotherapy-in-Japan-an-assessment-of-20-years-of-clinical-experience_2015_The-Lancet-Oncology.pdf - 894.00 kB
|- Cancer-and-high-body-mass-index-global-burden-global-effort-_2015_The-Lancet-Oncology.pdf - 93.00 kB
|- Building-a-global-consensus-approach-to-chordoma-a-position-paper-from-the-medical-and-patient-community_2015_The-Lancet-Oncology.pdf - 4.30 MB
|- Breast-cancer-vaccine-shows-promise_2015_The-Lancet-Oncology.pdf - 162.00 kB
|- Blinatumomab-a-new-era-of-treatment-for-adult-ALL-_2015_The-Lancet-Oncology.pdf - 175.00 kB
|- Black-cohosh-hot-flushes-and-breast-cancer_2015_The-Lancet-Oncology.pdf - 682.00 kB
|- Barefoot-to-Billionaire_2015_The-Lancet-Oncology.pdf - 401.00 kB
|- Assessment-of-the-quality-of-surgery-within-randomised-controlled-trials-for-the-treatment-of-gastro-oesophageal-cancer-a-systematic-review_2015_The-L.pdf - 205.00 kB
|- Anti-PD-L1-antibody-active-in-metastatic-bladder-cancer_2015_The-Lancet-Oncology.pdf - 162.00 kB
|- Anamorelin-for-patients-with-cancer-cachexia-an-integrated-analysis-of-two-phase-2-randomised-placebo-controlled-double-blind-trials_2015_The-Lancet-O.pdf - 528.00 kB
|- Afatinib-versus-cisplatin-based-chemotherapy-for-EGFR-mutation-positive-lung-adenocarcinoma-LUX-Lung-3-and-LUX-Lung-6-analysis-of-overall-survival-dat.pdf - 531.00 kB
|- Adjuvant-treatment-for-HER2-positive-breast-cancer_2015_The-Lancet-Oncology.pdf - 68.00 kB
|- Adjuvant-chemotherapy-after-preoperative-chemo-radiotherapy-and-surgery-for-patients-with-rectal-cancer-a-systematic-review-and-meta-analysis-of-indiv.pdf - 463.00 kB
|- Abiraterone-s-efficacy-confirmed-time-to-aim-higher_2015_The-Lancet-Oncology.pdf - 198.00 kB
|- Abiraterone-acetate-plus-prednisone-versus-placebo-plus-prednisone-in-chemotherapy-naive-men-with-metastatic-castration-resistant-prostate-cancer-COU-.pdf - 450.00 kB
|- A-well-earned-death_2015_The-Lancet-Oncology.pdf - 810.00 kB
|- A-new-standard-of-care-for-metastatic-melanoma-_2015_The-Lancet-Oncology.pdf - 74.00 kB
|- A-graphic-memoir-Probably-Nothing_2015_The-Lancet-Oncology.pdf - 609.00 kB
|- 56th-American-Society-of-Hematology-Annual-Meeting_2015_The-Lancet-Oncology.pdf - 117.00 kB
|- 2014-San-Antonio-Breast-Cancer-Symposium_2015_The-Lancet-Oncology.pdf - 171.00 kB
|- 19th-Society-for-Neuro-Oncology-Annual-Meeting_2015_The-Lancet-Oncology.pdf - 140.00 kB

[How to download](https://bpcam.bemobtrk.com/go/2ceec3aa-1ca2-46d6-b9ff-aaa5c184517c?jno=4496)